Triple-negative breast cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21067385.
- Also identified by DOI 10.1056/NEJMra1001389.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.
Medical subject headings
- Antineoplastic Agents
- Breast Neoplasms